Recent Posts »

DESPITE GROWING NUMBER OF SSRI BIRTH DEFECT LAWSUITS FDA SAYS IT LACKS CONCLUSIVE MEDICAL RESEARCH

DESPITE GROWING NUMBER OF SSRI BIRTH DEFECT LAWSUITS FDA SAYS IT LACKS CONCLUSIVE MEDICAL RESEARCH

September 28, 2012, No Comments

The newest class of anti-depressant drugs is called selective serotonin reuptake inhibitors (SSRIs) and marketed ...